2021
DOI: 10.1186/s12885-021-08332-3
|View full text |Cite
|
Sign up to set email alerts
|

Prognostic and clinicopathological insights of phosphodiesterase 9A gene as novel biomarker in human colorectal cancer

Abstract: Background PDE9A (Phosphodiesterase 9A) plays an important role in proliferation of cells, their differentiation and apoptosis via intracellular cGMP (cyclic guanosine monophosphate) signaling. The expression pattern of PDE9A is associated with diverse tumors and carcinomas. Therefore, PDE9A could be a prospective candidate as a therapeutic target in different types of carcinoma. The study presented here was designed to carry out the prognostic value as a biomarker of PDE9A in Colorectal cancer… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
8
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 12 publications
(8 citation statements)
references
References 83 publications
0
8
0
Order By: Relevance
“…Interference of cAMP/cGMP signaling pathway has been shown to be linked to tumorigenesis [155,197] and PDEs overexpression has been already described in several cancer types such happened for PDE11A and PDE8B, in adrenal hyperplasia/adenomas [162,198,199]. Indeed some PDEs have been already proposed as a potential biomarker for different tumoral contests [200][201][202][203][204] and we have proposed PDE8B as a promising biomarker for Leydig cell tumours. We believe that multi-omics will be useful to deeply analyze PDEs expression and activity for the translation of such findings in clinical practice.…”
Section: Discussionmentioning
confidence: 67%
“…Interference of cAMP/cGMP signaling pathway has been shown to be linked to tumorigenesis [155,197] and PDEs overexpression has been already described in several cancer types such happened for PDE11A and PDE8B, in adrenal hyperplasia/adenomas [162,198,199]. Indeed some PDEs have been already proposed as a potential biomarker for different tumoral contests [200][201][202][203][204] and we have proposed PDE8B as a promising biomarker for Leydig cell tumours. We believe that multi-omics will be useful to deeply analyze PDEs expression and activity for the translation of such findings in clinical practice.…”
Section: Discussionmentioning
confidence: 67%
“…VHL tumor suppressor protein can play a role in tumor suppression in multiple ways and the most common of them is targeting the HIF that mediated tumor suppression activity through polyubiquitylation and proteasomal degradation [ 66 ]. The major contribution of pVHL is to suppress clear-cell renal cell carcinoma in kidney cancer [ 66 , 67 ] and phosphodiesterase 9A gene as novel biomarker in human colorectal cancer [ 68 ].…”
Section: Discussionmentioning
confidence: 99%
“…The p value cutoff was 0.05. The student's t -test was used to generate a p value for expression or pathological stage analysis [ 37 , 38 ].…”
Section: Methodsmentioning
confidence: 99%
“…GeneMANIA. GeneMANIA (http://www.genemania .org) is a user-friendly website that provides information on protein and genetic interactions, pathways, coexpression, colocalization, and protein domain similarity of submitted genes [37,41].…”
Section: Methodsmentioning
confidence: 99%